James M. Stockman Cancer Institute — Frederick, Maryland

James M. Stockman Cancer Institute is a clinical research site located in Frederick, Maryland, United States 21702.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

James M. Stockman Cancer Institute has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Breast Cancer, Homeostatic Iron Regulator Gene-related Hereditary Hemochromatosis.

Sponsors: Odonate Therapeutics, Inc., CSL Behring.

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for James M. Stockman Cancer Institute?

James M. Stockman Cancer Institute has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has James M. Stockman Cancer Institute conducted?

James M. Stockman Cancer Institute has 2 clinical trials on record, with 1 currently active. Their work covers Breast Cancer, Homeostatic Iron Regulator Gene-related Hereditary Hemochromatosis.

Is James M. Stockman Cancer Institute accredited by Crixeo Health?

James M. Stockman Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about James M. Stockman Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.